Philips To Stop Selling CPAP Products Until FDA Consent Decree Is Finalized
WASHINGTON, D.C. — Koninklijke Philips NV said in a U.S. Securities and Exchange Commission filing that it has agreed to terms of a consent decree with the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article